Screener
Rapport Therapeutics, Inc. RAPP Accretion (Amortization) of Discounts and Premiums, Investments
Accretion (Amortization) of Discounts and Premiums, Investments at other companies
Other financials
Where this comes from
Reported directly by Rapport Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccretionAmortizationOfDiscountsAndPremiumsInvestments.
The source filing: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 7:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-210355
| Line item | For the three monthsended March 31, 2026 | For the three monthsended March 31, 2025 |
|---|---|---|
| Adjustments to reconcile net loss to net cash used in operating activities | ||
| Depreciation and amortization | 227 | 244 |
| Non-cash loss on sale of property and equipment | 153 | — |
| Net (accretion) and amortization of investments in marketable securities | (364) | (436) |
| Non-cash lease expense | 582 | 411 |
| Stock-based compensation expense | 6,963 | 4,040 |
| Changes in operating assets and liabilities: | ||
| Accounts receivable | (58) | — |
Item 1. Financial Statements.
FAQ
- What is Rapport Therapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments?
- Rapport Therapeutics, Inc. (RAPP) reported accretion (amortization) of discounts and premiums, investments of $364K in Q1 2026.
- How has Rapport Therapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments changed year-over-year?
- Rapport Therapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments decreased by 16.5% year-over-year, from $436K to $364K.
- What does accretion (amortization) of discounts and premiums, investments mean?
- Represents the non-cash adjustment to interest income or expense resulting from the amortization of premiums or accretion of discounts on investment securities. This adjustment reconciles the difference between the purchase price of an investment and its face value over the holding period. It is essential for understanding the true yield generated by the company's investment portfolio.
Ask your AI about Rapport Therapeutics, Inc.'s accretion (amortization) of discounts and premiums, investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude